Tag: Weight Loss
FDA Says Shortage of GLP-1 Tirzepatide Is Over
By Robin Foster HealthDay Reporter
THURSDAY, Dec. 19, 2024 (HealthDay News) -- The U.S. Food and Drug Administration re-issued a decision first made by the...
Even Modest Weight Loss Tied to Lower Health Care Spending
Finding seen for adults with overweight or obesity and either employer-sponsored insurance or Medicare coverage
Tirzepatide Yields Sustained Weight Reduction in Obesity, Prediabetes
Three years of tirzepatide also reduced risk for progression to type 2 diabetes compared with placebo
Novo Nordisk CEO Warns of Deaths Linked to Compounded Semaglutide
By Robin Foster HealthDay Reporter
THURSDAY, Nov. 7, 2024 (HealthDay News) -- The head of the company that makes the diabetes and obesity drugs Ozempic...
Expanding Access to Obesity Medications Could Avert 42,000 Deaths/Year
Impact of expanding access to GLP-1 receptor agonists, dual gastric inhibitory polypeptide and GLP-1 receptor agonists quantified
Weight Loss Durable for Years After Bariatric Surgery in Teens
Additionally, durable remission of coexisting conditions seen
Medicaid Covers GLP-1 Meds for Obesity in Just 13 States
By Dennis Thompson HealthDay Reporter
TUESDAY, Nov. 5, 2024 (HealthDay News) -- Low-income patients' access to blockbuster weight-loss drugs through Medicaid remains limited, a new...
Improvement Seen in Some Features of PCOS With Weight Loss Interventions
Interventions associated with significantly greater improvements in HOMA-IR, free androgen index, menstrual frequency
Risk for Suicidal Ideation, Attempts Down With GLP1-RA Treatment in Teens With Obesity
Glucagon-like peptide 1 receptor agonist prescription linked to reduction in risk for suicidal ideation or attempts
FDA Says Compounding Pharmacies Can Keep Making Weight-Loss Med Tirzepatide, for Now
By Robin Foster HealthDay Reporter
TUESDAY, Oct. 15, 2024 (HealthDay News) -- Pharmacists may continue making compounded versions of the weight-loss medication tirzepatide while the...
